Introduction

!
Although notable progress in diagnosis and therapy has been made in recent years, the 5-year survival of patients diagnosed with ductal adenocarcinoma of the pancreas is still less than 5 % [1]. To date, surgery is the only curative option for patients suffering from this aggressive entity. Nowadays in high-volume centers, this procedure can be performed with a mortality of 1 -3 % and morbidity of about 40 % [2] . However, only a minority of patients is resectable and 5-year survival rates of more than 20 % after resection are rare [2] . Radical resection of the tumor reaching negative resection margins is one of the strongest predictors for long-term survival [3] . Surgical exploration is the gold standard to determine unresectability. However, it is crucial to avoid passing the point of no return during explorative surgery. Otherwise, the resection has to be completed with the result of an R2-resection which implicates perioperative risk and does not improve prognosis [4] . Therefore, radiological assessment of resectability is an indispensible standard procedure before surgery with the goal to plan surgery by displaying the critical zones or to identify clearly unresectable patients. Surgical techniques have evolved significantly over the recent decades with attempts of more aggressive and radical resection. This is paralleled by technical advances in imaging technology regarding computed tomography (CT) and magnetic resonance imaging (MRI), which are the radiological modalities most frequently requested by surgeons for preoperative diagnostics and resectability assessment [5 -7] . Therefore, a continuous reappraisal of radiological methods and criteria in resectability assessment and exact knowledge of current surgical techniques are necessary for radiologists to give the correct advice to surgeons.
How to resect
!
Pancreatic cancer is located in 70 % of cases in the pancreatic head, in 20 % of cases in the body and 10 % are located in the pancreatic tail. The oncologically radical types of resection for pancreatic head cancer are en-bloc resection of the pancreatic head and duodenum with partial gastrectomy (Kausch-Whipple procedure) or, today's standard, pylorus preserving without gastric resection (Traverso-Longmire) [2] . For cancer of the pancreatic body and tail, a left pancreatectomy with splenectomy is performed [2] . Depending on the dimension of a left-sided carcinoma, the resection has to be extended towards the pancreatic head to reach tumor-free resection margins (subtotal left-sided pancreatectomy or total pancreatectomy). If the carcinoma is found to be of multilocular origin, a total pancreatectomy plus splenectomy is indicated to ensure complete removal of the tumor. Due to the absence of symptoms such as jaundice or gastric outlet stenosis, it is not unusual to diagnose left-sided pancreatic tumors at an advanced stage with involvement of adjacent organs such as the colon or stomach. In this case, multivisceral resection with complete removal of the tumor remains an option because the median survival is comparable to that of patients after standard pancreatic resections [8] . It can be deduced from the aforementioned characteristics of the different surgical options that location, intrapancreatic extent, and extension into adjacent tissues are the key information for surgical decision making. Regarding the extrapancreatic extent, both contrast-enhanced multiplanar CT and MRI are capable of displaying the tumor as well as the surrounding retroperitoneal and mesenteric fat, stomach, and bowel wall. Here, in case of absent or depleted separating fat planes, blurred or abolished boundary surfaces of tumor-adjacent tissues may indicate infiltration. Inside the pancreas, the highest possible contrast of the tumor to the surrounding pancreatic tissue is needed. For CT, it has been shown that after intravenous application of contrast media, pancreatic tissue enhances early, while ductal adenocarcinoma of the pancreas typically shows slow contrast accumulation [9] . The highest difference in radiodensity between tumor and pancreas is reached with a scan delay of approximately 40 seconds after the start of contrast administration [9] ( • " Fig. 1 ). This contrast phase is therefore indispensable for preoperative CT imaging of pancreatic cancer, and the results can be transferred to dynamic contrast-enhanced MRI as well, which is equally suited to detect and delineate tumors [10] . The use of bolus tracking can improve the correct timing of this pancreatic parenchymal phase in the individual patient by using an interval of approximately 25 seconds after bolus arrival in the abdominal aorta [11] .
Vessel invasion
!
The most common finding when determining unresectability besides the presence of metastases is the local invasion of major vascular structures by the primary tumor. In the case of pancreatic left resection, splenic vessels, even though their invasion is a negative prognostic factor [12] , are dispensable and are included in the en-bloc resection of the pancreatic tail and spleen. However, in the case of the most frequent location of pancreatic cancer, i. e., the pancreatic head, the surrounding vascular structures are complex and the arterial supply of the liver, stomach, and bowel, as well as the mesentericoportal venous axis has to be maintained in any kind of pancreatic resection. Many efforts have been made to facilitate complete tumor resection despite vessel involvement and technically, it is indeed possible to perform vessel resection and reconstruction. However, the surgical capabilities have to be set in relation to the achievable clinical outcome. With respect to the clinical relevance, a differentiation must be made between venous and arterial involvement [13, 14] . This is reflected by the current TNM staging system: the T3 category, representing the locally invasive but potentially resectable tumor, includes also focal invasion of the mesentericoportal venous axis, which can be handled surgically, while the T4 category, referring to the locally advanced unresectable tumor, includes invasion of the superior mesenteric artery (SMA) or the celiac axis [15] . The basis for discussion of the surgical options and prognosis related to the local tumor extent is the preoperative imaging with distinct analysis of the local tumor situation.
Veins
Tumor infiltration of the mesentericoportal axis is common in pancreatic head carcinoma. If the portal vein (PV) resection results in negative resection margins, survival rates similar to those of patients without PV resection can be achieved [16] . For that, tumor involvement of the PV is not a general contraindication for curative pancreatic head resection [13] . To maintain the venous drainage of the bowel after venous resection, several surgical procedures are available for venous reconstruction. These are segmental resection with reanastomosis (with or without interposition of a graft) and wall excision with patch plastic. Exact analysis of the portal venous confluence anatomy and its normal variants in this context is important and can be done with CT [17] . Extensive invasion of the mesenteric vein with separation of its branches as depicted by CT or MRI can even result in unre- Table 1 ). The intraoperative decision regarding how to manage venous involvement is made to a great part after the point of no return of a pancreatic head resection. This is why distinct preoperative knowledge of the extent of contact between the tumor and the mesentericoportal venous axis is so important. The radiological appearance of the tumor/vein interface can be with a fat plane between the tumor and the vein securely indicating non-involvement and dissectability, while complete encasement and vessel occlusion are a reliable sign for profound vessel invasion [18] . Any other direct tumor contact to the vessel may indicate invasion or a non-dissectable adhesion and has to be further characterized ( • " Fig. 1) . A recent study used simple descriptive criteria of the tumor/vein contact on CT images to predict the actual infiltration depth in the wall of the mesentericoportal veins and prognosis retrospectively in 358 patients resected for pancreatic cancer [19] . An increasing number and increasing depth of vessel wall invasions were found with increasing tumor-related narrowing of the vessel lumen (invasion into tunica media or deeper: no narrowing, 0 %; unilateral narrowing, 27 %; bilateral narrowing, 42 %; obstruction with collaterals, 63 %), par- Fig. 2 Carcinoma of the pancreatic head invading the superior mesenteric vein (CT, coronal MIP). The tumor (asterisk) occludes several main branches of the mesenteric vein (arrows). In this case, spontaneous collateralization of all venous territories after resection cannot be expected to be sufficient and surgical reconstruction of all relevant branches is problematic resulting in unresectability upon explorative surgery.
Abb. 2 Pankreaskopfkarzinom mit Infiltration der V. mesenterica superior (CT, koronare MIP). Der Tumor (Stern) verschließt mehrere Hauptäste der Mesenterialvene (Pfeile). In diesem Fall kann eine ausreichende Kollateralisierung nach Resektion nicht erwartet werden und die chirurgische Rekonstruktion von allen relevanten Ästen ist problematisch mit dem Ergebnis der Irresektabilität nach explorativer Laparotomie. 
Übersicht 25
This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
alleled by a significantly worse prognosis for patients with bilateral narrowing or obstruction compared with no or unilateral narrowing of the vein [19] . It has been shown that the use of multiplanar image reconstruction enhances accuracy when determining vein invasion [20] . Reporting the findings not only by description and axial images but also by multiplanar or threedimensional reconstructed images helps the surgeon to plan the procedure regarding complexity, duration, and material needed.
Arteries
Visceral arteries that are commonly affected by tumor growth are the SMA, the common hepatic artery (CHA) and the celiac artery (celiac trunk). Additional arterial resection during pancreatic head resection is associated with significantly increased perioperative mortality and poor survival compared to patients without necessity for additional arterial resection [21] . Arterial invasion is therefore considered an unresectability criterion ( • " Table 1 ). CT angiography (CTA) and MR angiography (MRA) are the methods of choice as they display both the tumor and the vessel at high image quality [22, 23] . An early study on CT in the preoperative evaluation of 25 patients with pancreatic cancer showed that the extent of circumferential tumor growth around the artery correlates with vessel wall invasion [24] . Tumor contact of more than half of the artery circumference and/or vessel constriction indicated unresectability at this artery segment with a sensitivity and specificity of 100 %. In case of lesser tumor contact without constriction, the tumor was still surgically unresectable at half of the evaluated arteries [24] . A contemporary study used a distinct analysis of the tumor/vessel interface describing it as a convex or concave contact [18] . Again, in the case of contact to the vessel, it was difficult to predict vessel wall invasion. This underlines that between separating the fat plane ( • " Fig. 1 ) and vessel encasement, there is a gray zone of tumor contact to the vessel without a clear-cut differentiation of cases with and without arterial wall infiltration. In contrast to the devices used in the studies cited above, new multidetector CT scanners with fewer movement artifacts and higher resolution enable high-quality three-dimensional multiplanar and curved image reconstruction. This facilitates improved depiction of arterial constrictions as well as distinct assessment of circumferential and longitudinal tumor contact independent of the vessel orientation. In a recent study evaluating the involvement of the SMA, the CHA, and the celiac trunk with multidetector CT using the traditional criteria of circumferential tumor contact and vessel constriction in 70 pancreatic cancer patients, the sensitivity and specificity were increased from 88 % and 94 % for axial images to 100 % and 93 % for additional multiplanar reconstructions [20] . Other recent studies showed similar results with high accuracy for the assessment of arterial invasion for CT and even for MRI using latest generation devices [10, 25, 26] . These improvements help to increase the rate of correct indications for and successful completions of open surgery with curative intent in pancreatic cancer patients [27] . However, despite the improvements of imaging in this respect, its remaining inaccuracy regarding arterial involvement demands surgical exploration, at least in equivocal cases, as this is still the gold standard in determining resectability.
Arterial variants
In pancreatic head resection, it is decisive to know about the individual arterial anatomy. Variants of hepatic arteries are common and can be relevant because tumor contact can occur at important arteries, which are not where the radiologist and the surgeon expect them to be [26] . Conditions which may lead to impaired arterial blood supply of the liver after pancreatic head resection are, e. g. preexisting severe stenosis of the celiac axis which becomes relevant after cutting off the collateral flow from the gastroduodenal artery (GDA) or accidental injury of an aberrant hepatic artery arising from the SMA behind or -rarely -inside the pancreatic head ( • " Fig. 3 ). Tumor infiltration of such an artery is a contraindication for resection just as of the SMA or a regular CHA ( • " Table 1) . As MRA and even more so CTA are highly accurate in displaying the arterial anatomy in the upper abdomen preoperatively, it is obligatory to report the relevant arterial anatomy in detail to the surgeon [22, 26, 28] .
Metastases
!
According to the German S3 guideline, pancreatic adenocarcinoma with hematogenous metastases or peritoneal spread is unresectable regardless of the local tumor extent since it does not improve the overall prognosis [13] . Palliative resection despite present metastases is currently being debated but is still not recommended outside studies. Thus, the exclusion of metastatic spread remains an important part of resectability assessment by imaging and surgical exploration ( • " Table 1 ).
Peritoneum
Regarding the peritoneal spread of pancreatic cancer, preoperative detection is problematic as at an early stage these lesions may appear in the form of small flat spots on the peritoneal surface, without sufficient dimensions to become visible on endoscopic ultrasound (EUS), CT, or MRI. Imaging is limited to the depiction of nodular lesions large enough to pass partial volume effects and to be differentiated from the adjacent structures, such as bowel wall or liver surface [29] . A recent study using mostly CT (95 %) for preoperative staging showed an overall rate of unanticipated peritoneal spread discovered during surgery of 5 % in 487 patients [30] . Positron emission tomography with F18-Fluorodeoxyglucose (FDG-PET), initially promising to overcome these problems, did not perform better than CT for the same reasons [31] . Often, only indirect findings, such as small amounts of free peritoneal fluid, can be depicted to raise the suspicion for peritoneal spread. Such findings and other risk factors for the presence of unanticipated peritoneal spread, like large primary tumors and tumor location in the pancreatic body or tail, should prompt the surgeon to start with laparoscopy instead of laparotomy in order to keep the trauma minimal in case of termination of the exploration [32] .
Liver
While CT has not shown any major improvement of the detection rates of liver metastases over the recent decade, MRI has experienced innovations like fast 3 D sequences and diffusion-weighted imaging (DWI) resulting in an increase of sensitivity from 70.2 % until 2004 to 84.9 % until 2010, which is superior to CT (75 %, metaanalysis on colorectal cancer metastases) [33] . For pancreatic cancer, a recent study reported a rate of unanticipated liver metastases of 12 % after negative preoperative imaging (mostly CT, 95 %) [30] . Furthermore, the rate of unanticipated hepatic and peritoneal metastases increased significantly from 10 % in patients who had been operated within 3 weeks after imaging to 20 %, 25 %, and 35 % in patients who had undergone surgery during the fourth, fifth, and sixth week after imaging, respectively [30] . Therefore, high-quality imaging of the liver and abdomen is needed shortly before surgery to avoid false-negative results. High-quality imaging means contrast-enhanced dynamic scanning using CT and/or MRI and, in the case of MRI, DWI besides the standard sequences [34, 35] . For both CT and MRI these prerequisites for liver imaging are compatible with pancreatic imaging optimized for resectability assessment. FDG-PET has the strength of a high specificity but a striking lack of sensitivity is reported regarding small liver metastases [35] . Therefore, FDG-PET is currently not the method of choice for resectability assessment of pancreatic cancer [13, 36] .
Lymph nodes
Pancreatic cancer resection with a standard lymphadenectomy includes the removal of lymph nodes in the peripancreatic region, along the hepatoduodenal ligament, the celiac trunk, and the SMA. Lymphatic metastases occur frequently and early with lymph node involvement in 75 % of pT3 tumors [37, 38] . In a large population-based study, N1 disease (n = 1,507) was associated with a significantly worse 5-year survival rate of 4.3 % compared with 11.3 % in N0 disease (n = 1,971), irrespective of other factors like grading, local extension, and number of assessed lymph nodes [39] . Despite this negative prognostic impact, locoregional lymph node metastases of pancreatic adenocarcinoma in general do not preclude a patient from the attempt of curative surgery [13, 39] . Given the high prevalence of lymphatic metastases, the minor role for unresectability, and the well-known problems of diagnostic imaging in the detection of involved lymph nodes in any kind of cancer, preoperative lymph node staging plays a minor role for surgical decision-making. The accuracy for the detection of lymph node metastasis by diagnostic imaging is limited as shown in a study on the detection of paraaortic lymph node metastases in 69 pancreatic cancer patients with all six lymph node positive cases being negative on CT, MRI, and FDG-PET [39] . Nevertheless, reporting enlarged, spherical, irregular-shaped, centrally necrotic, or otherwise suspicious nodes can be of importance for the surgeon especially when occurring outside the regions of standard lymphadenectomy because extended lymphadenectomy remains an option for these patients [41] .
Innovative treatment concepts
!
Neoadjuvant therapy
If radiological signs of locally advanced disease with arterial infiltration are present, the conversion of advanced pancreatic carcinoma from "non-resectable" to resectable seems to be a promising concept [42] . It remains to be seen what significance neoadjuvant treatment (chemotherapy and/or radiotherapy) will have in the future but already now radiologists are faced with the reassessment of resectability after the completion of neoadjuvant therapy. It is well known from other tumor entities that the accuracy of CT and MRI can be impaired after neoadjuvant treatment [43 -45] . Only a few studies have addressed this issue for pancreatic cancer with variable results. An early study concluded that the prediction of resectability by CT after neoadjuvant radiochemotherapy is comparable to cases without preceding therapy [46] . In contrast, a later study from the same group using CT to reassess initially borderline resectable tumors after neoadjuvant chemo-or chemoradiation therapy showed radiographic reduction of vascular involvement in only less than 1 % but an R0-resection rate as high as 80 % [47] . Another recent study confirmed this tendency of overestimation of the local tumor extent by CT and MRI after neoadjuvant therapy [48] , while Kim et al. observed some inaccuracy in T-staging by CT after neoadjuvant treatment but only minor effects on the assessment of resectability [49] .
Left pancreatic plus celiac trunk resection
Carcinoma of the body of the pancreas with involvement of the celiac trunk and/or the CHA is considered to be unresectable [13] . A radical distal pancreatectomy with splenectomy and enbloc resection of the celiac trunk without reconstruction of the celiac axis aims at providing a curative approach for these cases ( • " Table 1) . A recent metaanalysis of this approach showed survival rates equal to regular R0-resections [50, 51] . The Achilles heel of this procedure is the interruption of the direct arterial blood supply to the liver, bile ducts, and stomach. Despite collateral pathways via the SMA, pancreaticoduodenal arcades, and the GDA, arterial perfusion of critical organs can be compromised after this procedure, causing severe complications such as liver failure, biliary duct necrosis, perforation of the stomach, and ischemic ulcer [52, 53] . In order to avoid these complications, an interdisciplinary approach was introduced. Preoperative digital subtraction angiography with two catheters intubating the celiac trunk and the SMA provides important information about the status of the relevant vessels [53] . In the case of preexisting celiac trunk stenosis, spontaneous collateral flow can be seen from the SMA over pancreaticoduodenal arcades to the GDA supplying the hepatic artery. If no stenosis is present, a test occlusion of the celiac trunk with a balloon catheter can be employed to provoke collateral flow and to confirm thereby the existence of sufficient collateral arteries ( • " Fig. 4 ) [53] . To enhance the collateral flow already before the operation, which follows typically one week later, embo- 
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lization of the celiac trunk is recommended in most reports on this approach as this "training" of collateralization reliably prevents ischemic complications [53, 54] .
Conclusion
!
Surgical exploration is the gold standard for the determination of tumor resectability of pancreatic ductal adenocarcinoma. Preoperative imaging by CT or MRI can identify clearly unresectable tumors and is essential for surgical planning in resectable and borderline resectable patients. Radiologic resectability assessment comprises location and extent of the primary tumor including contact to adjacent vessels, vessel anatomy, presence of liver metastases, signs of peritoneal carcinomatosis, and presence of lymph node metastases. Even with modern imaging technologies, false-positive signs of unresectability may occur. Therefore, the indication for surgical exploration should be made broadly to not preclude any patient from the chance for complete tumor resection. 
